Form D · Other Technology

RepeatMD, Inc.

Houston, TX · CIK 0001962782

Offering snapshot reported Oct 2, 2023 · SEC filing

Reported sold: $26.3M
Investors reported: 4
Minimum accepted: $0
First sale: Jun 2, 2023

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$12,299,991 → $26,320,000
Reported investors2 → 4

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 2, 2023	Amendment	$26,320,000	$14,020,009vs Jun 14, 2023	4	SEC filing
Jul 10, 2023	Initial	$0	No comparison	1	SEC filing
Jun 14, 2023	Initial	$12,299,991	No comparison	2	SEC filing
Jan 20, 2023	Initial	$4,210,000	No comparison	4	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-484163

Total includes $1,515,123.29 in cancellation of indebtedness.

Source: Form D, filed Oct 2, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Christopher Chomenko	Director
Jacob Cole	Director
Aziz Gilani	Director
Jeffrey Matthews	Director, Executive
Philipp Sitter	Director, Executive
Matthew Suraci	Director

Issuer details

Industry: Other Technology (See others in industry)

Address:

5599 San Felipe 4 Th Floor
Houston, TX, 77056